Stocks making the biggest moves after-hours: Applied Materials, Baidu & more

Finance

Technicians work on machinery at the Applied Materials facility in Santa Clara, California.

David Paul Morris | Bloomberg | Getty Images

Check out the companies making headlines after the bell Thursday:

Applied Materials — Shares of Applied Materials rose 1.2% in after-hours trading on the back of fiscal third-quarter results that beat analyst expectations. The company reported earnings per share of $1.06 on revenue of $4.4 billion. Analysts polled by Refinitiv expected a profit of 95 cents per share on revenue of $4.18 billion. “By addressing our customers’ highest value problems, Applied is outperforming today and is positioned to grow faster than our markets over the next several years,” CEO Gary Dickerson said in a statement.

Baidu — Baidu shares fell about 5% in after-hours trading after the Chinese internet company reported second-quarter numbers that missed analyst expectations. Baidu posted a profit of RMB 8.84 per share, well below a Refinitiv estimate of $9.60 per share. Revenue for the quarter came in at RMB 22.55 billion and analysts expected sales of RMB 25.71 billion

Myriad Genetics — The Utah-based molecular diagnostic company saw its stock rise as much as 1.5% after the bell following mixed results for its fiscal fourth quarter. Myriad reported a loss of 31 cents per share. That was better than a FactSet estimate for a loss of 47 cents per share. Revenue, meanwhile came in just below expectations at $93.2 million. “Following the substantial decline in test volumes at the end of Q3 and beginning of Q4 due to COVID-19 social distancing policies we saw a significant recovery in test volume trends throughout the quarter,” said CEO R. Bryan Riggsbee.

Farfetch — Shares of the online luxury retailer jumped more than 5% after the company posted a smaller-than-expected loss for the second quarter. Farfetch reported a loss of 20 cents per share. Analysts polled by FactSet expected a loss of 29 cents per share. The company’s revenue for the quarter came in at $364.7 million, well above a forecast of $326.9 million.

Articles You May Like

Inflation is down — but the middle class is still feeling financial pressure. Here’s why
Here’s how to leverage higher income limits for the 0% capital gains bracket
Long-Term Care And Family Caregiving Finally May Get A Policy Moment
Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Linde falls after its guidance fails to wow the market. We’ve seen this movie before

Leave a Reply

Your email address will not be published. Required fields are marked *